Alghazali M, Löfgren A, Cheng N, Fagerlund K, Bjartell A. Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide. SJU [Internet]. 2020 Mar. 5 [cited 2024 Oct. 12];54(3):263-4. Available from: https://medicaljournalssweden.se/SJU/article/view/11700